Unity Biotechnology Stock (NASDAQ: UBX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.00 / 45.67K |
Day Range | - - - |
52 Wk Range | 1.22 - 2.60 |
Market Cap | $23.76M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 1.99% |
Days to Cover | 5.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Unity Biotechnology (NASDAQ:UBX) through any online brokerage.
Other companies in Unity Biotechnology’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Geovax Labs (NASDAQ:GOVX).
Unity Biotechnology has a consensus price target of $7.43.
The stock price for Unity Biotechnology (NASDAQ: UBX) is $1.41 last updated September 18, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Unity Biotechnology.
Unity Biotechnology’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Unity Biotechnology.
Unity Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.